Explore Fate Therapeutics' pipeline, financials, and market position to assess if its 75% drop reflects true value or ...

A Beachwood-based biotechnology company has secured $20 million in financing that will enable an expansion in personnel, ...

Stem cell-derived pancreatic islets are being studied as a rich transplantable source for insulin production, a therapeutic ...

Apr. 25, 2025 — Chimpanzee naive pluripotent stem cells (PSCs) can now be grown in cellular cultures, reveals a recent study. They successfully created chimpanzee early embryo models ...

Developed at the Children's Hospital of Philadelphia (CHOP) and called Zynteglo, the medicine uses the patient's own stem ...

Updated clinical and preclinical data showcase iPSC-derived off-the-shelf CAR T-cell therapy products for conditioning ...

Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune ...

Cambridge, Massachusetts– (Newsfile Corp. – May 8, 2025) – Ernexa Therapeutics (NASDAQ: ERNA), today announced its ...

The potential of big data analytics (BDA) to transform the prevention, diagnosis, and treatment of cardiovascular diseases ...

FUJIFILM Cellular Dynamics, Inc., a leading developer and manufacturer of human induced pluripotent stem cells (iPSC), today announces the appointment of Delara Motlagh, as its new chief operating ...